Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Shares, $0.001 par value
-
Shares outstanding
-
15,447,782
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
6,530,982
-
Shares change
-
-10,385
-
Total reported value, excl. options
-
$65,579,924
-
Value change
-
-$19,032
-
Number of buys
-
23
-
Number of sells
-
-23
-
Price
-
$10.04
Significant Holders of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) as of Q2 2020
65 filings reported holding GRX - Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value as of Q2 2020.
Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,530,982 shares
of 15,447,782 outstanding shares and own 42.28% of the company stock.
Largest 10 shareholders include Karpus Management, Inc. (1,146,022 shares), Karpus Management, Inc. (1,146,022 shares), WELLS FARGO & COMPANY/MN (513,247 shares), First Allied Advisory Services, Inc. (496,238 shares), LAZARD ASSET MANAGEMENT LLC (461,800 shares), MORGAN STANLEY (401,625 shares), GAMCO INVESTORS, INC. ET AL (289,716 shares), ROYAL BANK OF CANADA (249,983 shares), Cornerstone Advisors, LLC (186,507 shares), and RAYMOND JAMES & ASSOCIATES (176,442 shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.